Body mass index and outcomes in patients receiving chemotherapy for intermediate-grade B-cell non-Hodgkin lymphoma.

@article{Jones2010BodyMI,
  title={Body mass index and outcomes in patients receiving chemotherapy for intermediate-grade B-cell non-Hodgkin lymphoma.},
  author={Jeffrey A. Jones and Luis E. Fayad and Linda S. Elting and Maria Alma Rodriguez},
  journal={Leukemia & lymphoma},
  year={2010},
  volume={51 9},
  pages={1649-57}
}
We conducted a retrospective cohort study examining the influence of obesity on treatment outcome and survival among 712 patients with intermediate-grade B-cell NHL receiving frontline therapy between 1988 and 2001. Baseline adiposity was approximated by body mass index categorized according to the World Health Organization schema. Logistic and Cox proportional hazards regression modeling was used to adjust for baseline patient demographic, disease, and treatment variables. Approximately 37% of… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

Increased body mass index is associated with improved overall survival in diffuse large B-cell lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology • 2014
View 6 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…